Human stem cells for modeling heart disease and for drug discovery

Elena Matsa; Paul W. Burridge; Joseph C. Wu

doi:10.1126/scitranslmed.3008921

Human stem cells for modeling heart disease and for drug discovery

Elena Matsa
, Paul W. Burridge
, Joseph C. Wu

Stanford University

Research output: Contribution to journal › Review article › peer-review

Abstract

A major research focus in the field of cardiovascular medicine is the prospect of using stem cells and progenitor cells for cardiac regeneration. With the advent of induced pluripotent stem cell (iPSC) technology, major efforts are also underway to use iPSCs to model heart disease, to screen for new drugs, and to test candidate drugs for cardiotoxicity. Here, we discuss recent advances in the exciting fields of stem cells and cardiovascular disease.

Original language	English
Article number	239ps6
Journal	Science Translational Medicine
Volume	6
Issue number	239
DOIs	https://doi.org/10.1126/scitranslmed.3008921
Publication status	Published - 4 Jun 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1126/scitranslmed.3008921

Cite this

@article{07b42c7d0e174624a809b81641a268e7,

title = "Human stem cells for modeling heart disease and for drug discovery",

abstract = "A major research focus in the field of cardiovascular medicine is the prospect of using stem cells and progenitor cells for cardiac regeneration. With the advent of induced pluripotent stem cell (iPSC) technology, major efforts are also underway to use iPSCs to model heart disease, to screen for new drugs, and to test candidate drugs for cardiotoxicity. Here, we discuss recent advances in the exciting fields of stem cells and cardiovascular disease.",

author = "Elena Matsa and Burridge, \{Paul W.\} and Wu, \{Joseph C.\}",

year = "2014",

month = jun,

day = "4",

doi = "10.1126/scitranslmed.3008921",

language = "English",

volume = "6",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "239",

}

TY - JOUR

T1 - Human stem cells for modeling heart disease and for drug discovery

AU - Matsa, Elena

AU - Burridge, Paul W.

AU - Wu, Joseph C.

PY - 2014/6/4

Y1 - 2014/6/4

N2 - A major research focus in the field of cardiovascular medicine is the prospect of using stem cells and progenitor cells for cardiac regeneration. With the advent of induced pluripotent stem cell (iPSC) technology, major efforts are also underway to use iPSCs to model heart disease, to screen for new drugs, and to test candidate drugs for cardiotoxicity. Here, we discuss recent advances in the exciting fields of stem cells and cardiovascular disease.

AB - A major research focus in the field of cardiovascular medicine is the prospect of using stem cells and progenitor cells for cardiac regeneration. With the advent of induced pluripotent stem cell (iPSC) technology, major efforts are also underway to use iPSCs to model heart disease, to screen for new drugs, and to test candidate drugs for cardiotoxicity. Here, we discuss recent advances in the exciting fields of stem cells and cardiovascular disease.

UR - https://www.scopus.com/pages/publications/84903196154

U2 - 10.1126/scitranslmed.3008921

DO - 10.1126/scitranslmed.3008921

M3 - Review article

C2 - 24898747

AN - SCOPUS:84903196154

SN - 1946-6234

VL - 6

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 239

M1 - 239ps6

ER -

Human stem cells for modeling heart disease and for drug discovery

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this